QualityStocksNewsBreaks Archives - Page 465 of 1273

TuesdayJul 27, 2021 11:41 am

QualityStocksNewsBreaks – Mind Cure Health Inc. (CSE: MCUR) (OTCQB: MCURF) (FRA: 6MH) Announces Manufacture of Synthetic Ibogaine Moves to Second Stage

Mind Cure Health (CSE: MCUR) (OTCQB: MCURF) (FRA: 6MH), a leader in advanced proprietary technology and research for psychedelics, has begun the second stage of manufacturing pharmaceutical-grade ibogaine to be used in clinical research. According to the announcement, this stage will focus on assessing the quality of MINDCURE’s synthetic ibogaine when produced at scale to determine the timing and cost for commercial-scale manufacturing. The company intends to manufacture pharmaceutical-grade ibogaine to provide researchers with a consistent supply of sustainable, high-quality, reliable psychedelic substance. The company has already filed patent applications for two routes of chemical synthesis of ibogaine, with both…

TuesdayJul 27, 2021 11:32 am

QualityStocksNewsBreaks – Friendable Inc. (FDBL) Delivers on Key Milestone with Release of Fan Pass 2.0

Friendable (OTC: FDBL), a mobile technology and marketing company, today announced it has completed another corporate milestone, delivering version 2.0 of its Fan Pass livestream platform to the Apple App and Google Play stores. According to the update, Friendable submitted the platform to both stores on July 24, 2021, marking the one-year anniversary of the company’s official launch of Fan Pass. Version 2.0 includes all new UI/UX and many updated features for artists and fans. “Our talented development team worked hard to release v2.0 on the anniversary of our original launch,” said Friendable CEO Robert A. Rositano Jr. “We believe…

TuesdayJul 27, 2021 10:44 am

QualityStocksNewsBreaks – Petroteq Energy Inc. (TSX.V: PQE) (OTC: PQEFF) Announces Contact from Uppgard Konsult AB

Petroteq Energy (TSX.V: PQE) (OTC: PQEFF), an integrated oil company focused on the development and implementation of its proprietary oil-extraction and remediation technologies, today announced that its securities counsel has been contacted by the client of Uppgard Konsult AB, (the “bidder”), through legal counsel. The update clarifies that, while there is no guarantee that any discussions will result in any meaningful discussions or a transaction, the company has advised the bidder 's Canadian counsel that it is open and willing to initiate discussions. To view the full press release, visit https://ibn.fm/6Izni About Petroteq Energy Inc. Petroteq is an integrated oil…

TuesdayJul 27, 2021 10:10 am

QualityStocksNewsBreaks – reAlpha Tapping Hot New Trend in Real Estate Investment

reAlpha, known as the Robinhood of Airbnb, was featured in a recent Bloomberg article titled, “Investors Chasing Housing Target Massive Pools of Airbnb Rentals.” The piece discusses a hot new trend investors are tapping into as they hunt for returns in the frenzied U.S. real estate market. This involves building massive portfolios of houses to rent out on Airbnb. “A recent filing reveals that Dublin, Ohio-based reAlpha is seeking to spend as much as $1.5 billion, including debt, to buy short-term rentals at an unprecedented scale. The money would be enough to purchase roughly 5,000 homes, Chief Executive Officer Giri…

TuesdayJul 27, 2021 10:04 am

QualityStocksNewsBreaks – Flora Growth Corp. (NASDAQ: FLGC) to Partner with Avaria to Bring Award-Winning KaLaya Brand to LATAM Distribution Network

Flora Growth Corp. (NASDAQ: FLGC), an all-outdoor cultivator and manufacturer of global cannabis products and brands, today announced its entry into a non-binding letter of intent (“LOI”) to form a joint venture (“JV”) with Avaria Inc. Canadian-based Avaria is the manufacturer and owner of KaLaya — an award-winning pain cream distributed across Canada. Through the JV, Flora Growth will manage registration, sales and distribution of KaLaya products in Colombia, Mexico, and other LATAM countries, while Avaria will supply finished product. Flora Growth and Avaria will equally divide the profits from the sale of KaLaya products under the JV, increasing the…

TuesdayJul 27, 2021 9:58 am

QualityStocksNewsBreaks – Green Hygienics Holdings Inc. (GRYN) Names New Senior VP of Global Sales and Business Development

Green Hygienics (OTCQB: GRYN) has appointed a new senior vice president. David Racz, a seasoned pharmaceutical executive, has been named senior VP of global sales and business development for the innovative, tech-driven company. Racz has garnered extensive experience in the both the pharma and cannabis sectors, having served in global, senior-level positions with well-known pharmaceutical companies including Pfizer, GlaxoSmithKline and Novartis. At Pfizer, he was vice president of sales and human resources, overseeing the largest expansion in Pfizer’s sales force in history. At SmithKline Beecham, he managed more than 4,000 sales, marketing and R&D employees, who were located in 20 countries…

TuesdayJul 27, 2021 9:53 am

QualityStocksNewsBreaks – Grapefruit USA Inc. (GPFT) Shares Insta Message from ELove: ‘Best Thing on the Market’

Grapefruit USA (OTCQB: GPFT), a premiere California-based cannabis and hemp company, and its flagship product, Hourglass THC+CBD Patchless Patch Topical Cream, has received an Instagram endorsement from Grammy Award-winning writer, producer and director Damien Matthias, known as ELove. ELove has performed and co-produced with LL Cool J, one of Def Jams Records’ first artists. He also played a key role in launching the careers of Tupac Shakur and John Forte of the Fugees and was integrally involved in the pre-internet marketing team of Def Jam Records, one of the most successful independent labels of all time. “Hourglass, the best thing…

MondayJul 26, 2021 3:53 pm

QualityStocksNewsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX) Secures $3.8M Through Warrant Exercises

Lexaria Bioscience Corp. (NASDAQ: LEXX, LEXXW), a global innovator in drug delivery platforms, today announced its receipt of US$3,817,643 from the exercise of share purchase warrants. According to the update, the company issued the warrants pursuant to its January 2021 public underwritten offering. The shares and warrants issued thereunder were registered pursuant to a Form S-1 Registration Statement (No. 333-250326), as amended, and a Form S-1MEF Registration Statement (No. 333-252031). The warrants were exercised into 580,189 shares of voting common stock of the company, each at an exercise price of US$6.58. The company will utilize all proceeds received from the…

MondayJul 26, 2021 2:54 pm

QualityStocksNewsBreaks – Sidoti & Company LLC Chooses IBN, IW for August Virtual Microcap Conference Communications Coverage

Sidoti is collaborating with InvestorBrandNetwork (“IBN”) and InvestorWire (“IW”) to provide coverage for its Sidoti August Virtual Microcap Conference. The prestigious two-day event, which will be presented in a digital format, is slated for Aug. 18-19, 2021. The conference offers a carefully vetted list of some 45 companies from a variety of different industries, including technology, telecommunication services, consumer discretionary, clean energy, industrials and more. Each company will have an opportunity to present a corporate overview as well as meet with sector-focused investors. A highly respected independent securities research firm, Sidoti has offered well-regarded small and microcap corporate conferences for the past 20 years. The firm…

MondayJul 26, 2021 1:20 pm

QualityStocksNewsBreaks – Tryp Therapeutics Inc. (CSE: TRYP) (OTCQB: TRYPF) Announces Strategic Board Appointments

Tryp Therapeutics (CSE: TRYP) (OTCQB: TRYPF), a pharmaceutical company focused on developing psilocybin-based compounds for diseases with unmet medical needs through accelerated regulatory pathways, today announced the appointment of Robin Carhart-Harris, Ph.D. as chairman of Tryp’s Scientific Advisory Board (“SAB”) and Daniel Clauw, M.D. as a new member of the SAB. Dr. Carhart-Harris initially joined Tryp’s SAB in February 2021 and has been instrumental in advising the company through the development of its Psilocybin-for-Neuropsychiatric Disorders (“PFN(TM)”) program. Dr. Clauw is a world-leading expert in fibromyalgia and other nociplastic pain indications. “With today’s announcement, I would like to thank Dr. Robin…

Site Search

Company Search

Category: QualityStocksNewsBreaks